We are live on ! Find out more
AMBI

Ambit Biosciences Corp
AMBI

Delisted

AMBI was delisted on the 10th of November, 2014.

Back to rankings

49 hedge funds and large institutions have $154M invested in Ambit Biosciences Corp in 2014 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

129% more capital invested

Capital invested by funds: $67M → $154M (+$86.5M)

118% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 11

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

80% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 5

36% more funds holding

Funds holding: 36 → 49 (+13)

Holders
49
Holders Change
+13
Holders Change %
+36.11%
% of All Funds
1.42%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
24
Increased
9
Reduced
5
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
+$2.37M
2
U
UBS
Switzerland
+$1.27M
3
GP
GLG Partners
United Kingdom
+$1.24M
4
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
+$1.19M
5
AQR Capital Management
AQR Capital Management
Connecticut
+$1.11M

Top Sellers

Rank Fund Capital Flow
1
GPP
Great Point Partners
Connecticut
-$3.12M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$2.75M
3
WC
Wexford Capital
Florida
-$2.28M
4
SFM
Sphera Funds Management
Israel
-$1.92M
5
AG
Artal Group
Luxembourg
-$1.73M
Name Holding Trade Value Shares
Change 		Change in
Stake
HM
26
Harvest Management
New York
$613K +$274K +39,800 New
California Public Employees Retirement System
27
California Public Employees Retirement System
California
$533K – – –
O
28
OppenheimerFunds
New York
$522K +$233K +33,915 New
RIL
29
Rothschild Investment LLC
Illinois
$472K +$29.5K +4,300 +16%
BFA
30
BlackRock Fund Advisors
California
$388K -$12.6K -1,836 -7%
LOAMU
31
Lombard Odier Asset Management (USA)
New York
$385K +$172K +25,000 New
CL
32
CSS LLC
Illinois
$379K +$169K +24,622 New
Bank of New York Mellon
33
Bank of New York Mellon
New York
$369K – – –
JG
34
Jefferies Group
New York
$354K +$158K +23,000 New
OAC
35
OMERS Administration Corp
Ontario, Canada
$331K +$148K +21,500 New
Northern Trust
36
Northern Trust
Illinois
$301K -$529 -77 -0.4%
N
37
Natixis
France
$241K +$108K +15,663 New
PCM
38
Prelude Capital Management
New York
$77K +$34.4K +5,000 New
Ameriprise
39
Ameriprise
Minnesota
$49K +$22K +3,196 New
FNYS
40
First New York Securities
New York
$46.2K +$20.6K +3,000 New
BA
41
BlackRock Advisors
Delaware
$33K -$359K -52,264 -96%
BIM
42
BlackRock Investment Management
Delaware
$31K +$502 +73 +4%
Bank of America
43
Bank of America
North Carolina
$15K +$6.56K +955 New
TRCT
44
Tower Research Capital (TRC)
New York
$8K -$13.8K -2,002 -80%
MTIP
45
Magee Thomson Investment Partners
California
$7K +$941 +137 +47%
Citigroup
46
Citigroup
New York
$6K +$481 +70 +24%
LTFS
47
Ladenburg Thalmann Financial Services
Florida
$1K – – –
Manulife (Manufacturers Life Insurance)
48
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$3 – – –
Fidelity Investments
49
Fidelity Investments
Massachusetts
– -$2.75M -398,679 Closed
WC
50
Wexford Capital
Florida
– -$2.28M -329,460 Closed
1
2
3

AMBI Hedge Fund Activity: Q3 2014 in Review

49 of the 3,448 institutional investors tracked by Wall St. Rank reported a position in Ambit Biosciences Corp (AMBI) for Q3 2014, worth a combined $154M — up 129% from $67M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new AMBI positions and 11 closed out — a net gain of 13 holders — while 9 added to existing stakes and 5 trimmed.

The largest buyer was Baker Bros. Advisors, adding an estimated $2.37M. The largest seller was Great Point Partners, cutting an estimated $3.12M.

  • 49 institutional investors held Ambit Biosciences Corp (AMBI) as of Q3 2014, up from 36 in Q2 2014.
  • Funds reported $154M of Ambit Biosciences Corp stock for Q3 2014, up 129% quarter-over-quarter.
  • 24 funds opened new Ambit Biosciences Corp positions in Q3 2014 and 11 closed out, a net change of +13 holders.
  • The largest Ambit Biosciences Corp buyer in Q3 2014 was Baker Bros. Advisors, an estimated $2.37M added.
  • The largest Ambit Biosciences Corp seller in Q3 2014 was Great Point Partners, an estimated $3.12M sold.

Based on aggregated 13F filings for Q3 2014.